about
Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood cultureRapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamideThe Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutolImprovement in plasma drug activity during the early treatment interval among Tanzanian patients with multidrug-resistant tuberculosis.Plasma drug activity in patients on treatment for multidrug-resistant tuberculosisUnderstanding pharmacokinetics to improve tuberculosis treatment outcome.Plasma drug activity assay for treatment optimization in tuberculosis patients.The next 10 years for tuberculosis vaccines: do we have the right plans in place?Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis.Population pharmacokinetic/pharmacodynamic analysis of the bactericidal activities of sutezolid (PNU-100480) and its major metabolite against intracellular Mycobacterium tuberculosis in ex vivo whole-blood cultures of patients with pulmonary tubercuDisruption of the gene homologous to mammalian Nramp1 in Mycobacterium tuberculosis does not affect virulence in miceMycobacterium tuberculosis pathogenesis and molecular determinants of virulenceSynthetic peptides that exert antimicrobial activities in whole blood and blood-derived matricesBiomarker-assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosisHigh-throughput sequencing enhanced phage display identifies peptides that bind mycobacteriaTranscriptional profiling of Mycobacterium tuberculosis replicating ex vivo in blood from HIV- and HIV+ subjectsA new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.A novel mycobacterial In Vitro infection assay identifies differences of induced macrophage apoptosis between CD4+ and CD8+ T cells.Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes.Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosisActivity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood cultureInhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosis.Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.Tuberculosis vaccines: present and future.A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development.The Cross-species Mycobacterial Growth Inhibition Assay (MGIA) Project 2010-2014.In vitro and ex vivo characterization of lectin-labeled Mycobacterium tuberculosis antigen-containing microspheres for enhanced oral delivery.Detection and characterization of nocardia from patients diagnosed as tuberculosis in egypt.Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosisApplication of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.Plasma contributes to the antimicrobial activity of whole blood against Mycobacterium tuberculosis.Functional Analysis of Phagocyte Activity in Whole Blood from HIV/Tuberculosis-Infected Individuals Using a Novel Flow Cytometry-Based Assay.Survival and replication of clinical Mycobacterium tuberculosis isolates in the context of human innate immunity.Action of fluoroquinolones and Linezolid on logarithmic- and stationary-phase culture of Mycobacterium tuberculosis.Coadministration of Allopurinol To Increase Antimycobacterial Efficacy of Pyrazinamide as Evaluated in a Whole-Blood Bactericidal Activity Model.Mycobacterial growth inhibition is associated with trained innate immunity.Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial.Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial.
P2860
Q24564359-AFC4FFF1-DBE9-417D-A799-34B0A2348682Q28478966-7B19F9CD-1662-4DCF-B3E3-8767BD059D18Q28487116-8414E03E-5F73-41CC-81EA-DE4E295D42F6Q28545109-4F61DD01-44C3-43BB-B5E5-9E54CA10CAA3Q30411475-8F0D9B9E-BE55-42C1-899D-D24E01334F65Q30411703-401FE9A0-B627-47A3-B16D-E958EB055D1FQ30426583-9156A1FF-DC9E-4B70-8B75-BDFB89D09344Q33659150-A6562AEB-E0BD-402E-BB18-DE30E9740DA8Q33767388-91BA370E-4EB1-44F9-80C2-E7FDBE1EE837Q33798120-609EF46C-635B-46FB-B47B-F03B9F0C3028Q34128847-C9DB8011-33EA-43A5-ACF9-AFA9929D9FA3Q34213787-A8E6AF4B-72D5-4B94-99EE-E1CB4E282196Q34252687-1D749DAE-B7F1-4B57-AD54-3D202E6ECD09Q34529109-F4F8E4D3-C573-4776-A41B-F3BF529CC28BQ35050264-392AEA86-BF1A-4773-8C89-823C7D8354E7Q35154909-DDC5119B-EF80-41BD-9607-9F49F19AB31BQ36103177-4D356A33-F583-48E5-8C9A-74E65ED88C63Q36281275-79306889-A448-47A3-978B-2B929B95DE73Q36540944-2A452F9B-1B07-4104-8DEC-1C31AEF397B7Q36669451-79864A32-977A-4F87-8F18-D794A751D70EQ36893907-7FEA9628-BFD7-4336-AE3B-CDA426E47CBAQ37335461-798D5E03-E7AB-4DEF-9B88-B7FDE91ADDB5Q37365050-3F0B319D-2594-4437-9A64-3445DC9627D3Q37671936-4BA314E9-89AC-403F-AC02-3CA0A08669C3Q37678618-8BE71E1E-BC82-4470-BCED-2A5903214372Q37754908-3BEF2609-10A0-49F4-8FC3-D78BDA4DF871Q38627717-3BBCCBF3-BD91-4F57-980B-28F6158D4733Q38682059-8C2C6C5A-ED64-422E-8898-3731C3F64C8EQ39103503-C317104C-552B-46B2-BA6C-5DC1846D97CDQ39527438-C2C5C89F-3ED9-4F7C-A1D6-235B4EA76784Q39625931-01298726-65D5-440D-A38A-4C1EB18666BEQ40060240-2270244D-B612-451B-B4C2-5EE3D7721D08Q40565501-F7EB256C-6570-4551-84C7-E2EC45E2CD30Q42369087-EB9224EC-73F7-4116-8BF2-FF6BD52FB188Q42727223-E5CA4FE7-C789-44A5-ABB4-BB63F38258A2Q45137197-8C7628B9-AF1D-43DD-81B1-D7304441D453Q48713291-762746BB-B06C-460D-8EDC-03B5E29692D0Q52376102-475DF518-17FD-44AD-B001-046E59543E61Q53408541-9DC4B1B0-D3D4-47A5-ADDB-A11C835ED9F4Q53687059-0FC80CE6-8437-4901-A630-065A765A06C9
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
A whole blood bactericidal assay for tuberculosis.
@en
A whole blood bactericidal assay for tuberculosis.
@nl
type
label
A whole blood bactericidal assay for tuberculosis.
@en
A whole blood bactericidal assay for tuberculosis.
@nl
prefLabel
A whole blood bactericidal assay for tuberculosis.
@en
A whole blood bactericidal assay for tuberculosis.
@nl
P2093
P356
P1476
A whole blood bactericidal assay for tuberculosis.
@en
P2093
Phillips M
Ribeiro FC
P304
P356
10.1086/319679
P407
P577
2001-03-08T00:00:00Z